ATE177010T1 - Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie - Google Patents

Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie

Info

Publication number
ATE177010T1
ATE177010T1 AT92903516T AT92903516T ATE177010T1 AT E177010 T1 ATE177010 T1 AT E177010T1 AT 92903516 T AT92903516 T AT 92903516T AT 92903516 T AT92903516 T AT 92903516T AT E177010 T1 ATE177010 T1 AT E177010T1
Authority
AT
Austria
Prior art keywords
vaccines
against swine
immune boosting
swine pleuropneumonia
pleuropneumonia
Prior art date
Application number
AT92903516T
Other languages
English (en)
Inventor
Krishnaswamy Iyengar Dayalu
Nathan Zygraich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE177010T1 publication Critical patent/ATE177010T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92903516T 1990-12-19 1991-12-19 Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie ATE177010T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63100990A 1990-12-19 1990-12-19

Publications (1)

Publication Number Publication Date
ATE177010T1 true ATE177010T1 (de) 1999-03-15

Family

ID=24529423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903516T ATE177010T1 (de) 1990-12-19 1991-12-19 Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie

Country Status (9)

Country Link
EP (1) EP0563288B1 (de)
JP (1) JPH06503351A (de)
KR (1) KR100258772B1 (de)
AT (1) ATE177010T1 (de)
AU (1) AU662116B2 (de)
CA (1) CA2098719A1 (de)
DE (1) DE69130953T2 (de)
DK (1) DK0563288T3 (de)
WO (1) WO1992011023A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025742A1 (en) * 1994-03-22 1995-09-28 Pfizer Inc. Pasteurellaceae antigens and related vaccines
US6713071B1 (en) * 1998-10-22 2004-03-30 Pfizer Inc. Proteins from actinobacillus pleuropneumoniae

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2029219B (en) * 1978-08-24 1982-12-15 Gilmour N Pasteurellosis vaccines
GB2202851B (en) * 1987-03-24 1990-12-19 Nat Res Dev Proteinaceous material of p. haemolytica and vaccine against pasteurella
NL8802007A (nl) * 1988-08-12 1990-03-01 Centraal Diergeneeskundig Inst Vaccin, geschikt voor de profylaxe respectievelijk de bestrijding van de door haemophilus pleuropneumoniae teweeggebrachte ziekte bij varkens alsmede werkwijze voor het winnen van extracellulair eiwitachtig materiaal van haemophilus pleuropneumonie, geschikt voor toepassing in dergelijke vaccins.
FR2644346B1 (fr) * 1989-03-20 1994-05-13 Rhone Merieux Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins
EP0453024B1 (de) * 1990-04-20 1995-05-31 Akzo Nobel N.V. Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae

Also Published As

Publication number Publication date
CA2098719A1 (en) 1992-06-20
AU9168591A (en) 1992-07-22
JPH06503351A (ja) 1994-04-14
EP0563288B1 (de) 1999-03-03
KR930703006A (ko) 1993-11-29
DE69130953T2 (de) 1999-07-08
EP0563288A4 (en) 1994-08-24
KR100258772B1 (ko) 2000-08-01
AU662116B2 (en) 1995-08-24
DE69130953D1 (de) 1999-04-08
DK0563288T3 (da) 1999-09-27
EP0563288A1 (de) 1993-10-06
WO1992011023A1 (en) 1992-07-09

Similar Documents

Publication Publication Date Title
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
CY2007016I2 (el) Εμβολιο ιου θηλωματος
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
ATE103315T1 (de) Verwendung haertbarer cycloaliphaten-derivate in duebelmassen.
IL106968A0 (en) Potentiation of immunogenic response
DK0454735T3 (da) Vaccine sammensætning
EA199900069A1 (ru) Вакцинная композиция против малярии
MX9102145A (es) Composiciones epoxi avanzadas, composiciones curables y productos curados.
DK0552240T3 (da) Ny metode til behandling af depression
ITMI913092A0 (it) Vaccino di poxvirus ricombinate del virus del morbillo
DE69332045D1 (de) Hepatistherapeutikum
DE69034166D1 (de) Azellulärer Impfstoff
DE3882781D1 (de) Impfstoff gegen pasteurella.
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
DK0597838T3 (da) Vaccinesammensætninger
ATE177010T1 (de) Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
DE69025414D1 (de) Vakzin-Zusammensetzung
ITRM910385A0 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni.
NO901959D0 (no) Malaria-vaksine.
DE69232962D1 (de) Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält
DE69228063D1 (de) Abgeschwächter rückmutierter virusimpfstoff gegen mareks krankheit serotyp-1
MX9100472A (es) Composiciones epoxi avanzadas,composiciones curables y productos curados

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties